Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NIH
MedTech
FDA clears its first fingerstick hepatitis C diagnostic test
The FDA has greenlit its first point-of-care diagnostic test for hepatitis C, in a bid to quickly connect patients with antiviral drugs.
Conor Hale
Jul 2, 2024 11:04am
NIAID is 'on the ball' with bird flu research, but gaps remain
Jun 10, 2024 5:50am
NIH pairs primary care with research in $30M program
Jun 10, 2024 4:30am
Joe Biden reportedly chooses NIH head—Chutes & Ladders
Apr 21, 2023 9:30am
Biotech pipeline hosts 163 potential meds for mental illness
Jan 30, 2023 5:30am
NRx tanks as peptide fails NIH trial in severe COVID-19 patients
May 26, 2022 7:50am